FDA Investigator Christine A Harman, PhD

Christine A Harman, PhD has conducted inspections on 19 sites in 7 countries as of 29 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
19
Last Inspection Date:
29 Apr 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Israel, Hungary, Spain, Netherlands, Belgium
FDA Investigators that have inspected at least one site in common with Christine A Harman, PhD:
Alan G Baer, Alan L Truong, Alexander M Kay, Alexey Khrenov, PhD, Alifiya H Ghadiali, Andrew A Hoopes, Andrew Byrnes, PhD, Andrew W Harmon, Angela K Shen, Anita Narula, PhD, Ann Marie Montemurro, Ann Marie Schofield, Anthony R Bucks, Ashar P Parikh, Ashley A Mutawakkil, Astrida B Mattson, Barbara Janine Breithaupt, Bradley Dworak, PhD, Brandon L Mariner, Brentley S Collins, Brett R Havranek, Brian D Nicholson, Brittany D Terhar, Bruce D Meade, Burnell M Henry, Carl A Huffman, III, Caryn M Mcnab, CDR Donald Ertel, Christian D Lynch (CDL), Christopher R Czajka, Cody D Rickman, Connie P Rezendes, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia L Kelley, Damaris Y Hernandez, David E Bailey, David J Eide, David M Beltran, Dawn E Barkans, Deborah M Trout, Derya C Coursey, Dolores E Price, Don H Bark, PhD, Donald L Myers, Edwin Melendez, Eileen A Liu, Elizabeth C Lessey Morillon, Ellen Huang, Emmanuel Adu Gyamfi, PhD, Eric M Mueller, PharmD, Eric M Padgett, Eric Peng, Francis A Guidry, Gene D Arcy, Gerard Pde Leon, Gloria J Baca, MS, Grace I Cortesini, Graeme E Price, Graeme Price, Gwyn G Dickinson, Hector A Carrero, Heika R Bounds, Heika R Tait, Helen B Ricalde, Helen Y Saccone, Holly Brevig, Jacqueline Mdiaz Albertini, James A Jagon, James E Keller, PhD, James I Giefer, James R Evans, Janet B Abt, Jazmine N Still, Jean Lhu Primmer, Jennifer L Bridgewater, Jin Gao, Joan Johnson, Joey V Quitania, Joseph George, Joseph R Lambert, Julie D Bringger, Kari M Johansen, Kathryn A Krentz, Kelley, Kelly K Nachtigal, Ken L Bowers, Kenneth O Gee, PhD, Kevin D Kallander, Kristin M Abaonza, Laura K Demaster, Laurel A Beer, LCDR Debra Emerson, Lewis K Antwi, Lilia L Bi, Linda Thai, Lisa K Capron, Lisa P Oakes, Lori Peters, Lynda L Perry, PhD, Margaret A Smithers, Maria Pkelly Doggett, MBA, Marijo B Kambere, PhD, Marion Michaelis, Marissa S Steinhagen, Mariza M Jafary, Mark W Babbitt, Marlene L Davis, Marsha W Major, Maryna C Eichelberger, PhD, Matthew M Schuckmann, Matthew R Sleeter, Maxine H Wong, Michael R Goga, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Mikel T Wright, Mindy M Chou, Miriam M Ngundi, Monica M Mcclure, Mra Mcculloughj, Myra K Casey, Nancy G Schmidt, Natalya M Ananyeva, Nawab A Siddiqui, Omotunde O Osunsanmi, Ou Ma, Patsy J Domingo, Paula A Trost, Phillip C Thai, Phillip Thai, Prabhu P Raju, Pratik S Upadhyay, DDC, Quyen T Tran, Ralph H Vocque, Randy L Self, Rebecca Rodriguez, Reginald D Neal, Richard Heath Coats, Richard L Rutherford, Rita K Kabaso, Robert C Coleman, Robert D Tollefsen, Robert J Ham, Roger F Zabinski, Rose Ashley, S Lori Brown, PhD MPH, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sarah E Rhoades, Sarah Forney, Scott A Golladay, Scott E Norris, Sergey S Akimov, Shafiq S Ahadi, Sharmila Shrestha, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Steven C Derrick, Steven D Kehoe, Steven P Donald, Sukhanya Jayachandra, Susan F Laska, MS, Susan M Jackson, Susan Yu, Susanna E Ford, Takele H Argaw, Tara L Breckenridge, Tara L Greene, Terri L Dodds, Thai D Truong, Thomas J Arista, Tina S Roecklein, Tracy K Li, Travis S Bradley, Unnee Ranjan, Uttaniti Limchumroon (Tom), Walsworth, Wei Wang, PhD, William D Tingley, Xiomara Copeland, Xiuju Lu, Y N Nguyen, Yiping Jia, Zainab Y Mansaray Storms, Zi Qiang Gu

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more